FDA Grants Emergency Use Authorization For Moderna’s Coronavirus Vaccine
- December 21, 2020
The New York Times (12/18, A1, Grady, Goodnough, Weiland) reported, “The Food and Drug Administration on Friday authorized the coronavirus vaccine made by Moderna for emergency use, allowing the shipment of millions more doses across the nation.” The agency’s decision “will make Moderna’s vaccine the second to reach the American public, after the one by Pfizer and BioNTech, which was authorized just one week ago.”
Bloomberg (12/19, Edney, Langreth) reported that like Pfizer’s vaccine, Moderna’s vaccine “is administered in a two-dose regimen.”
Among other sources covering the story are The Hill (12/18, Weixel), NPR (12/18, Dwyer), Politico (12/18, Owermohle), STAT (12/18, Herper), USA Today (12/18, Weintraub), the Wall Street Journal (12/18, A1, Loftus, Burton, Subscription Publication), and Reuters (12/18, Erman, Singh, Maddipatla, Spalding, Henderson, Steenhuysen).